SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

12 Aug 2024 Evaluate
The sales for the June 2024 quarter moved up 27.38% to Rs. 880.34 millions as compared to Rs. 691.14 millions during the corresponding quarter last year.Profit for the quarter ended June 2024 increased merely by0.27% to Rs. 78.26  millions from Rs. 78.05 millions.OP of the company witnessed a marginal growth to 125.85 millions from 114.03 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 880.34 691.14 27.38 880.34 691.14 27.38 3289.73 2750.52 19.60
Other Income 62.67 38.02 64.83 62.67 38.02 64.83 159.01 76.12 108.89
PBIDT 125.85 114.03 10.37 125.85 114.03 10.37 601.94 356.96 68.63
Interest 4.43 2.43 82.30 4.43 2.43 82.30 13.38 11.97 11.78
PBDT 121.42 111.60 8.80 121.42 111.60 8.80 588.56 344.99 70.60
Depreciation 21.40 19.99 7.05 21.40 19.99 7.05 81.48 78.99 3.15
PBT 100.02 91.61 9.18 100.02 91.61 9.18 507.08 266.00 90.63
TAX 21.76 13.56 60.47 21.76 13.56 60.47 121.89 64.81 88.07
Deferred Tax 3.51 1.72 104.07 3.51 1.72 104.07 7.76 -7.30 -206.30
PAT 78.26 78.05 0.27 78.26 78.05 0.27 385.19 201.19 91.46
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 14.30 16.50 -13.35 14.30 16.50 -13.35 18.30 12.98 40.99

NGL Fine-Chem Share Price

2271.70 16.65 (0.74%)
17-Apr-2026 09:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1686.70
Dr. Reddys Lab 1215.55
Cipla 1228.40
Zydus Lifesciences 937.95
Lupin 2323.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×